Northern Trust’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-835,773
| Closed | -$20M | – | 4677 |
|
|
2021
Q1 | $20M | Sell |
835,773
-84,427
| -9% | -$1.57M | ﹤0.01% | 1825 |
|
|
2020
Q4 | $13.4M | Sell |
920,200
-42,054
| -4% | -$557K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $13.7M | Sell |
962,254
-19,835
| -2% | -$303K | ﹤0.01% | 1904 |
|
|
2020
Q2 | $14.4M | Buy |
982,089
+237,281
| +32% | +$2.41M | ﹤0.01% | 1859 |
|
|
2020
Q1 | $3.07M | Sell |
744,808
-14,784
| -2% | -$69.3K | ﹤0.01% | 2597 |
|
|
2019
Q4 | $3.65M | Buy |
759,592
+2,386
| +0.3% | +$13.2K | ﹤0.01% | 2776 |
|
|
2019
Q3 | $4.59M | Buy |
757,206
+81,376
| +12% | +$508K | ﹤0.01% | 2598 |
|
|
2019
Q2 | $4.39M | Buy |
675,830
+11,530
| +2% | +$81.2K | ﹤0.01% | 2632 |
|
|
2019
Q1 | $4.71M | Sell |
664,300
-25,810
| -4% | -$170K | ﹤0.01% | 2598 |
|
|
2018
Q4 | $3.35M | Buy |
690,110
+9,785
| +1% | +$51K | ﹤0.01% | 2750 |
|
|
2018
Q3 | $5M | Buy |
680,325
+17,488
| +3% | +$128K | ﹤0.01% | 2682 |
|
|
2018
Q2 | $4.23M | Buy |
662,837
+22,692
| +4% | +$150K | ﹤0.01% | 2770 |
|
|
2018
Q1 | $3.48M | Sell |
640,145
-58,383
| -8% | -$290K | ﹤0.01% | 2796 |
|
|
2017
Q4 | $2.91M | Sell |
698,528
-673
| -0.1% | -$4.05K | ﹤0.01% | 2912 |
|
|
2017
Q3 | $6.73M | Buy |
699,201
+68,441
| +11% | +$711K | ﹤0.01% | 2439 |
|
|
2017
Q2 | $7.46M | Buy |
630,760
+52,984
| +9% | +$677K | ﹤0.01% | 2359 |
|
|
2017
Q1 | $7.41M | Buy |
577,776
+12,034
| +2% | +$145K | ﹤0.01% | 2325 |
|
|
2016
Q4 | $6.92M | Buy |
565,742
+67,864
| +14% | +$806K | ﹤0.01% | 2337 |
|
|
2016
Q3 | $5.88M | Sell |
497,878
-1,509
| -0.3% | -$14.6K | ﹤0.01% | 2420 |
|
|
2016
Q2 | $4.34M | Buy |
499,387
+11,770
| +2% | +$80.7K | ﹤0.01% | 2547 |
|
|
2016
Q1 | $2.58M | Buy |
487,617
+10,667
| +2% | +$59.4K | ﹤0.01% | 2826 |
|
|
2015
Q4 | $3.7M | Buy |
476,950
+6,046
| +1% | +$46.4K | ﹤0.01% | 2656 |
|
|
2015
Q3 | $3.71M | Buy |
470,904
+6,276
| +1% | +$58K | ﹤0.01% | 2643 |
|
|
2015
Q2 | $4.21M | Buy |
464,628
+8,556
| +2% | +$86.3K | ﹤0.01% | 2630 |
|
|
2015
Q1 | $5.92M | Buy |
456,072
+93
| +0% | +$1.22K | ﹤0.01% | 2405 |
|
|
2014
Q4 | $6.21M | Sell |
455,979
-8,895
| -2% | -$99.5K | ﹤0.01% | 2365 |
|
|
2014
Q3 | $4.17M | Buy |
464,874
+26,244
| +6% | +$282K | ﹤0.01% | 2625 |
|
|
2014
Q2 | $5.93M | Sell |
438,630
-28,939
| -6% | -$302K | ﹤0.01% | 2400 |
|
|
2014
Q1 | $4.65M | Sell |
467,569
-44,278
| -9% | -$550K | ﹤0.01% | 2612 |
|
|
2013
Q4 | $6.8M | Buy |
511,847
+22,214
| +5% | +$270K | ﹤0.01% | 2341 |
|
|
2013
Q3 | $5.94M | Buy |
489,633
+346,564
| +242% | +$3.72M | ﹤0.01% | 2393 |
|
|
2013
Q2 | $1.48M | Buy |
+143,069
| New | +$1.97M | ﹤0.01% | 3145 |
|
Northern Trust's GNMK Position: Q2 2021 in Review
Northern Trust sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 835,773 shares — an estimated $20M sold.
Northern Trust first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $20M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Northern Trust reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Northern Trust sold 835,773 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $20M.
- Northern Trust first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- Northern Trust's GenMark Diagnostics, Inc position peaked at $20M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Northern Trust's 13F filing for Q2 2021, filed 13 Aug 2021.